Details for New Drug Application (NDA): 209389
✉ Email this page to a colleague
The generic ingredient in ONDANSETRON is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the ondansetron hydrochloride profile page.
Summary for 209389
Tradename: | ONDANSETRON |
Applicant: | Ipca Labs Ltd |
Ingredient: | ondansetron |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 209389
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 4MG | ||||
Approval Date: | Oct 30, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 8MG | ||||
Approval Date: | Oct 30, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription